期刊文献+

五环三萜类柴胡皂苷单体对白念珠菌伊曲康唑耐药株活性研究 被引量:6

Effect of monomers(pentaeyclic triterpennoids of saikosaponines) from Buplerum kunmingense against itraconazole-resistant Candida albicans strains
下载PDF
导出
摘要 目的从柴胡中提取具有抗真菌活性的五环三萜类单体Bp3,研究该单体对伊曲康唑耐药白念珠菌菌株的作用及其与伊曲康唑的相互作用。方法参照CLSI标准,采用棋盘微量稀释法,测定单用Bp3、伊曲康唑及两者联合使用时对20株伊曲康唑耐药白念珠菌菌株的MIC,计算部分抑菌浓度指数(FIC),判定两药相互作用。结果单独用药时Bp3及伊曲康唑对伊曲康唑耐药白念珠菌菌株MIC的几何均数值(GM值)分别为1.941μg/mL和1.008μg/mL。联合用药时Bp3和伊曲康唑的GM值分别降低为1.189μg/mL和0.346μg/mL。2种药物单用和联合使用时MIC值差异均有统计学意义(P<0.05),联用时在20株耐药株均表现为协同或相加作用。结论五环三萜类单体Bp3对白念珠菌伊曲康唑耐药株有一定的抑制作用,且与伊曲康唑有协同或相加作用。 Objective To study the antifungal activity of the monomer Bp3(saikosaponins) isolated from Bupleurum kunmingense with chemical structure of Pentaeyclic triterpennoids.Methods According to the Standard of Clinical and Laboratory Standards Institute(CLSI),the microdilution method and checkerboard microdilution method were used to determine the antifungal activities of Bp3,itraconazole and their combination to itraconazole-resistant C.albicans strains respectively.Results The minimal inhibitory concentrations(MIC) of Bp3 and itraconazole alone were 1.941 μg/mL and 1.008 μg/mL,respectively.In the combination,the MIC of Bp3 and itraconazole were 1.189 μg/mL and 0.346 μg/mL respectively.The geometric mean(MG) of Bp3 and itraconazole were significant reduce in MIC.The interaction analysis showed that synergistic and additive effects were showed in these isolates.Conclusion Comparing with any single agent,the combination of Bp3 and itraconazole was significantly more active to itraconazole-resistant C.albicans strains.
出处 《中国真菌学杂志》 2012年第1期8-11,共4页 Chinese Journal of Mycology
关键词 柴胡 单体 白念珠菌 伊曲康唑 体外抗菌活性 Buplerum kunmingense monomers Candida albicans itraconazole in vitro antifungal activity
  • 相关文献

参考文献13

  • 1Bueid A,Howard SJ,Moore CB,et al.Azole antifungal resist-ance in Aspergillus fumigatus:2008 and 2009[J].J AntimicrobChemother,2010,65(10):2116-2118.
  • 2高清云,沈亮亮,施伟民,叶元康,潘胜利,武济民.Bp3抗耐氟康唑白念珠菌活性研究[J].同济大学学报(医学版),2009,30(1):40-43. 被引量:2
  • 3沈亮亮 叶元康.致病性真菌体外药物敏感性实验的方法.同济大学学报:医学版,2004,25:96-99.
  • 4沈亮亮,叶元康.氟康唑与5-氟胞嘧啶体外联合抗白念珠菌临床分离株的研究[J].同济大学学报(医学版),2005,26(6):19-21. 被引量:10
  • 5姜淼,黄欣,沈亮亮,周斐,屠韡燕,施伟民.2种中药单体对念珠菌的体外药敏研究[J].中国真菌学杂志,2011,6(1):26-30. 被引量:7
  • 6李岷,沈永年,吕桂霞,刘维达.棘白菌素对氟康唑耐药的念珠菌体外药物敏感性的研究[J].中国真菌学杂志,2009,4(2):78-81. 被引量:8
  • 7Laverdiere M,LabbéAC,Restieri C,et,al.Susceptibility pat-terns of Candida species recovered from Canadian intensive careunits[J].J Crit Care,2007,22(3):245-250.
  • 8Howard SJ,Cerar D,Anderson MJ,et al.Frequency and evolu-tion of Azole resistance in Aspergillus fumigatus associated withtreatment failure[J].Emerg Infect Dis,2009,15(7):1068-1076.
  • 9Howard SJ,Harrison E,Bowyer P,et al.Cryptic species andazole resistance in the Aspergillus niger complex[J].AntimicrobAgents Chemother,2011,55(10):4802-4809.
  • 10Cuenca-Estrella M.Antifungal agents in the treatment of sys-temic infections:relevance of mechanism of action,activity pro-file and resistances[J].Rev Esp Quimioter,2010,23(4):169-176.

二级参考文献27

  • 1王海燕,荒井雅吉,供田洋,大村智.微生物来源的Azole类抗真菌活性增强剂——FKI-0076A、B和C的研究[J].中国抗生素杂志,2001,26(2):89-93. 被引量:4
  • 2沈亮亮,叶元康.氟康唑与5-氟胞嘧啶体外联合抗白念珠菌临床分离株的研究[J].同济大学学报(医学版),2005,26(6):19-21. 被引量:10
  • 3Laverdiere M, Labbe AC, Restieri C, et, al. Susceptibility patterns of Candida species recovered from Canadian intensive care units [ J ]. J Crit Care, 2007,22 ( 3 ) : 245 - 250.
  • 4Fridkin SK,Jarvis WR.Epidemiology of nosocomial fungal infections.Clin Microbiol Rev,1996,9(5):499-511.
  • 5Morace G,Borghi E.Fungal infections in ICU patients:epidemiology and the role of diagnostics.Minerva Anestesiol,2010,76(11):950-956.
  • 6Perea S.Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency patients.Antimicrob Agents Chemother,2001,45:2676.
  • 7Hua Quan,Ying-Ying Cao,Zheng Xu,et al.Potent In vitro synergism of fluconazole and berberine chloride against clinical isolates of candida albicans resistant to fluconazole.Antimicrobial Agents and Chemotherapy,2006,50(3):1096-1099.
  • 8Atkinson BA,Bocanegra R,Colombo AL,et al.Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B.Antimicrob Agents Chemother,1994,38:1604-7.
  • 9Khodavandi A,Alizadeh F,Harmal NS,et al.Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.FEMS Microbiol Lett,2011,315(2):87-93.
  • 10Canton E,Peman J,Gobernado M,et al.Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard,time-kill,and Etest methods.Antimicrob Agents Chemother,2005,49:1593-6.

共引文献32

同被引文献143

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部